Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 4.44 USD -1.11% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Goodrx Holdings Inc?
Write Note

Goodrx Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Goodrx Holdings Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Goodrx Holdings Inc
NASDAQ:GDRX
Revenue
$750.3m
CAGR 3-Years
11%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Revenue
$2.7B
CAGR 3-Years
15%
CAGR 5-Years
21%
CAGR 10-Years
25%
Inspire Medical Systems Inc
NYSE:INSP
Revenue
$755.6m
CAGR 3-Years
55%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Revenue
$475.4m
CAGR 3-Years
32%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Revenue
$1.1B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
10%
W
Waystar Holding Corp
NASDAQ:WAY
Revenue
$791m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Goodrx Holdings Inc
Revenue Breakdown

Breakdown by Geography
Goodrx Holdings Inc

Not Available

Breakdown by Segments
Goodrx Holdings Inc

Total Revenue: 750.3m USD
100%
Prescription Transactions Revenue: 550.7m USD
73.4%
Subscription Revenue: 94.4m USD
12.6%
Pharma Manufacturer Solutions Revenue: 85.1m USD
11.3%
Other Revenue: 20.1m USD
2.7%
Show More
Show Less

Goodrx Holdings Inc
Glance View

Market Cap
1.7B USD
Industry
Health Care

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

GDRX Intrinsic Value
10.95 USD
Undervaluation 59%
Intrinsic Value
Price

See Also

What is Goodrx Holdings Inc's Revenue?
Revenue
750.3m USD

Based on the financial report for Dec 31, 2023, Goodrx Holdings Inc's Revenue amounts to 750.3m USD.

What is Goodrx Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
25%

Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Goodrx Holdings Inc have been 11% over the past three years , 25% over the past five years .

Back to Top